Related references
Note: Only part of the references are listed.Breast cancer genomics and immuno-oncological markers to guide immune therapies
D. Hammerl et al.
SEMINARS IN CANCER BIOLOGY (2018)
Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Human CD4+ CD25+ CD127hi cells and the Th1/Th2 phenotype
Aditi Narsale et al.
CLINICAL IMMUNOLOGY (2018)
Tumor-infiltrating lymphocytes and ductal carcinoma in situ of the breast: friends or foes?
Marie Colombe Agahozo et al.
MODERN PATHOLOGY (2018)
Understanding the tumor immune microenvironment (TIME) for effective therapy
Mikhail Binnewies et al.
NATURE MEDICINE (2018)
Circulating and disseminated tumour cells - mechanisms of immune surveillance and escape
Malte Mohme et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Immune Escape in Breast Cancer During In Situ to Invasive Carcinoma Transition
Carlos R. Gil Del Alcazar et al.
CANCER DISCOVERY (2017)
Tumor-infiltrating lymphocytes in Breast Cancer and implications for clinical practice
Debora de Melo Gagliato et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2017)
Cancer Statistics in China, 2015
Wanqing Chen et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Prognostic and predictive value of tumor in early breast cancer
Carmen Criscitiello et al.
CANCER TREATMENT REVIEWS (2016)
Relevance of tumor-infiltrating lymphocytes in breast cancer
Sathana Dushyanthen et al.
BMC MEDICINE (2015)
Prognostic value of different cut-off levels of Ki-67 in breast cancer: a systematic review and meta-analysis of 64,196 patients
Fausto Petrelli et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Characterization and Clinical Implication of Th1/Th2/Th17 Cytokines Produced from Three-Dimensionally Cultured Tumor Tissues Resected from Breast Cancer Patients
Anna Kiyomi et al.
TRANSLATIONAL ONCOLOGY (2015)
CD4+ follicular helper T cell infiltration predicts breast cancer survival
Chunyan Gu-Trantien et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Innate and adaptive immune cells in the tumor microenvironment
Thomas F. Gajewski et al.
NATURE IMMUNOLOGY (2013)
Saikosaponin A mediates the inflammatory response by inhibiting the MAPK and NF-κB pathways in LPS-stimulated RAW 264.7 cells
Jie Zhu et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2013)
Tumor-Infiltrating CD8+ Lymphocytes Predict Clinical Outcome in Breast Cancer
Sahar M. A. Mahmoud et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Saikosaponin a inhibits the proliferation and activation of T cells through cell cycle arrest and induction of apoptosis
Yang Sun et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2009)
IL-12, but not IFN-alpha, promotes STAT4 activation and Th1 development in murine CD4(+) T cells expressing a chimeric murine/human Stat2 gene
ME Persky et al.
JOURNAL OF IMMUNOLOGY (2005)
Sustained IL-12 signaling is required for Th1 development
V Athie-Morales et al.
JOURNAL OF IMMUNOLOGY (2004)
Saikosaponin-A induces apoptotic mechanism in human breast MDA-MB-231 and MCF-7 cancer cells
JC Chen et al.
AMERICAN JOURNAL OF CHINESE MEDICINE (2003)
STAT4 serine phosphorylation is critical for IL-12-induced IFN-γ production but not for cell proliferation
A Morinobu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Mechanism of 7,12-dimethylbenz[α]anthracene-induced immunotoxicity:: Role of metabolic activation at the target organ
M Miyata et al.
JAPANESE JOURNAL OF PHARMACOLOGY (2001)
Share Paper
